Demonstrates improved anti-inflammatory activity in rats using optimized ketoprofen SLN gel, suggesting advances in topical NSAID delivery.
) and tumor necrosis factor-α (TNF-α) levels by 55.6% and 58.4%, respectively, compared with the carrageenan control group. Furthermore, the SLN-based gel demonstrated markedly higher bioadhesion (+81%) and a two-fold increase in permeation flux compared with the pure drug gel.Overall, the optimized ketoprofen SLN gel achieved enhanced bioadhesion, skin permeation, and anti-inflammatory efficacy, confirming the potential of lipid nanoparticle-based systems for topical NSAID delivery. This strategy provides a rational, statistically optimized platform for improving localized therapy while minimizing systemic adverse effects.
No takes yet. Share an insight, caveat, or question.
Alrashidi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: